Premier Health of America Inc. (TSXV:PHA.H)
Canada · Delayed Price · Currency is CAD 0.0050
-0.0050 (-50.00%)
At close: Jun 23, 2026
Premier Health of America Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 87.67 | 101.97 | 158.19 | 90.39 | 80.51 | 66.63 | |
Revenue Growth | -42.83% | -35.54% | 75.01% | 12.28% | 20.83% | 221.26% |
Cost of Revenue | 73.48 | 85.36 | 130.3 | 67.05 | 60.42 | 50.37 |
Gross Profit | 14.2 | 16.61 | 27.9 | 23.35 | 20.08 | 16.25 |
Selling, General & Admin | 15.83 | 17.27 | 21.87 | 15.57 | 14.32 | 10.53 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 1.88 |
Operating Expenses | 23.45 | 25.21 | 28.34 | 20.05 | 17.75 | 12.82 |
Operating Income | -9.25 | -8.6 | -0.45 | 3.3 | 2.34 | 3.44 |
Interest Expense | -5.26 | -5.54 | -5.73 | -1.96 | -0.95 | -0.92 |
Interest & Investment Income | 0.24 | 0.24 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.26 | -0.15 | -0.05 | - | - | 0 |
EBT Excluding Unusual Items | -14.53 | -14.05 | -6.23 | 1.34 | 1.39 | 2.52 |
Impairment of Goodwill | -3.07 | -3.07 | -5.5 | -1.5 | - | - |
Gain (Loss) on Sale of Assets | 0.31 | 0.12 | 0.01 | - | - | - |
Asset Writedown | -0.56 | -0.56 | - | -0.11 | - | - |
Other Unusual Items | 0.39 | 0.15 | -0.49 | -0.27 | -0.15 | - |
Pretax Income | -17.45 | -17.41 | -12.22 | -0.55 | 1.24 | 2.52 |
Income Tax Expense | -1.73 | -1.97 | 0.27 | 1.16 | 1.35 | 1.02 |
Net Income | -15.73 | -15.44 | -12.49 | -1.7 | -0.11 | 1.5 |
Net Income to Common | -15.73 | -15.44 | -12.49 | -1.7 | -0.11 | 1.5 |
Net Income Growth | - | - | - | - | - | 5260.80% |
Shares Outstanding (Basic) | 56 | 56 | 55 | 56 | 55 | 50 |
Shares Outstanding (Diluted) | 56 | 56 | 55 | 56 | 55 | 53 |
Shares Change | - | 0.06% | -0.29% | 0.77% | 4.15% | 50.04% |
EPS (Basic) | -0.28 | -0.28 | -0.23 | -0.03 | -0.00 | 0.03 |
EPS (Diluted) | -0.28 | -0.28 | -0.23 | -0.03 | -0.00 | 0.03 |
EPS Growth | - | - | - | - | - | 3339.80% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 13.31 | 12.09 | 10.07 | -1.76 | 3.43 | 0.1 |
Free Cash Flow Per Share | 0.24 | 0.22 | 0.18 | -0.03 | 0.06 | 0.00 |
Gross Margin | 16.19% | 16.29% | 17.63% | 25.83% | 24.95% | 24.39% |
Operating Margin | -10.55% | -8.43% | -0.28% | 3.65% | 2.90% | 5.16% |
Profit Margin | -17.94% | -15.14% | -7.89% | -1.88% | -0.14% | 2.25% |
Free Cash Flow Margin | 15.18% | 11.86% | 6.37% | -1.94% | 4.26% | 0.15% |
EBITDA | -3.23 | -2.37 | 5.01 | 6.9 | 5.38 | 5.67 |
EBITDA Margin | -3.68% | -2.33% | 3.17% | 7.64% | 6.69% | 8.52% |
D&A For EBITDA | 6.02 | 6.23 | 5.46 | 3.6 | 3.05 | 2.24 |
EBIT | -9.25 | -8.6 | -0.45 | 3.3 | 2.34 | 3.44 |
EBIT Margin | -10.55% | -8.43% | -0.28% | 3.65% | 2.90% | 5.16% |
Effective Tax Rate | - | - | - | - | 109.02% | 40.64% |